Letters Antiphospholipid syndrome

What benefit has the label?

BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c2983 (Published 09 June 2010) Cite this as: BMJ 2010;340:c2983
  1. Christoph Pechlaner, associate professor of internal medicine1
  1. 1Innsbruck Medical University, University Hospital, A-6020 Innsbruck, Austria
  1. christoph.pechlaner{at}i-med.ac.at

    “Doctors believe to greatly benefit a patient by giving his illness a name” (Immanuel Kant). The benefit of the label “antiphospholipid syndrome”1 is unclear—how treatment should differ for patients with the syndrome (disease and positive antiphospholipid antibody tests) from those without (disease and negative tests) is …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription